JOURNAL BROWSE
Search
Advanced SearchSearch Tips
The use of natural remedies to treat osteoarthritis
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : TANG [HUMANITAS MEDICINE]
  • Volume 6, Issue 1,  2016, pp.1.1-1.9
  • Publisher : Association of Humanitas Medicine
  • DOI : 10.5667/tang.2015.0023
 Title & Authors
The use of natural remedies to treat osteoarthritis
Tan, Boon Hooi; Ong, Chin Eng;
  PDF(new window)
 Abstract
Osteoarthritis (OA) is the leading medical condition for which patients use alternative treatments including the natural remedies. The aim of this review is to describe the dietary supplements and herbal remedies most commonly used in patients with osteoarthritis with an emphasis on the efficacy and safety of these natural remedies. Glucosamine and chondroitin sulfate, two of the molecular building blocks found in articular cartilage, are the most commonly used remedies in OA treatment. Most clinical researches suggest that glucosamine and chondroitin show efficacy in reducing or improving symptoms and their ability to arrest progression of the disease or regenerate damaged cartilage. Patented formulations of both remedies are recommended by several therapeutic guidelines for use as first line background OA treatment. Reliable evidence that the combination is more effective than either agent alone is however still lacking. Several other herbs or remedies are promoted for treating osteoarthritis such as S-adenosylmethionine, methylsulfonylmethane, Harpagophytum procumbens (devil`s claw), Curcuma longa (turmeric), Zingiber officinale (ginger), and capsaicin but there is no reliable evidence on long-term efficacy or safety. The clinical usefulness of these remedies is therefore rather limited currently.
 Keywords
osteoarthritis;natural remedies;glucosamine;chondroitin;herbs;
 Language
English
 Cited by
 References
1.
Ahmed MI, Afifi MI, Younos IH. Harpagophytum procumbens (Devil’s Claw): a possible natural anti-inflammatory agent (an experimental study). Iran J Pharmacol Ther. 2005;4:54–63.

2.
Altman, RD. Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations. Expert Rev Clin Pharmacol. 2009;2:359-371. crossref(new window)

3.
Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. 2001;44:2531-2538. crossref(new window)

4.
Anderson J, Nicolosi R, Borzelleca J. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol. 2005;43:187-201. crossref(new window)

5.
Barcelo HA, Wiemeyer JCM, Sagasta CL, Macias M, Barreira JC. Effect of S-adenosylmethionine on experimental osteoarthritis in rabbits. Am J Med. 1987;83:55-59. crossref(new window)

6.
Barclay TS, Tsourounis C, McCart GM. Glucosamine. Ann Pharmacother. 1998;32:574-579. crossref(new window)

7.
Barthe L, Woodley J, Lavit M, Przybylski C, Philibert C, Houin G. In vitro intestinal degradation and absorption of chondroitin sulfate, a glycosaminoglycan drug. Arzneimittel forschung. 2004;54:286-292.

8.
Bassleer CT, Combal JP, Bougaret S, Malaise M. Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage. 1998;6:196-204. crossref(new window)

9.
Bliddal H, Rosetzsky A, Schlichting P, Weidner MS, Andersen LA, Ibfelt HH, Christensen K, Jensen ON, Barslev J. A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage. 2000;8:9-12. crossref(new window)

10.
Brien S, Lewith GT, McGregor G. Devil’s Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety. J Altern Complement Med. 2006;12:981-993. crossref(new window)

11.
Bruyère O, Cooper C, Pelletier JP, Branco J, Luisa Brandi M, Guillemin F, Hochberg MC, Kanis JA, Kvien TK, Martel-Pelletier J, Rizzoli R, Silverman S, Reginster JY. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44:253-263. crossref(new window)

12.
Bruyere O, Pavelka K, Rovati LC, Deroisy R, Olejarova M, Gatterova J, Giacovelli G, Reginster JY. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause. 2004;11:138-143. crossref(new window)

13.
Bucsi L, Poór G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage. 1998;6:31-36. crossref(new window)

14.
Calamia V, Ruiz-Romero C, Rocha B, Fernández-Puente P, Mateos J, Montell E, Vergés J, Blanco FJ. Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes. Arthritis Res Ther. 2010; 12:R138. crossref(new window)

15.
Cameron M, Chrubasik S. Topical herbal therapies for treating osteoarthritis. Cochrane Database Syst Rev. 2013;5:CD010538

16.
Cameron M, Gagnier JJ, Little CV, Parsons TJ, Blumle A, Chrubasik S. Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Part 1: osteoarthritis. Phytother Res. 2009;23:1497-1515. crossref(new window)

17.
Catelan SC, Belentani RM, Marques LC, Silva ER, Silva MA, Caparroz-Assef SM, Cuman RKN, Bersani-Amado CA. The role of adrenalcorticosteroids in the anti-inflammatory effect of the whole extract of Harpagophytum procumbens in rats. Phytomedicine. 2006;13:446-451. crossref(new window)

18.
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat activated ion channel in the pain pathway. Nature. 1997;389:816-824. crossref(new window)

19.
Cheleschi S, Pascarelli NA, Valacchi G, Di Capua A, Biava M, Belmonte G, Giordani A, Sticozzi C, Anzini M, Fioravanti A. Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β. Int Immunopharmacol. 2015;28:794-801. crossref(new window)

20.
Cho JW, Lee KS, Kim CW. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NFkappaB and MAPKs as potential upstream targets. Int J Mol Med. 2007;19:469-474.

21.
Clarkson C, Staerk D, Hansen SH, Smith PJ, Jaroszewski JW. Identification of major and minor constituents of Harpagophytum procumbens using HPLC-SPE-NMR and HPLC/ESIMS/APCIMS. J Nat Prod. 2006;69:1280-1288. crossref(new window)

22.
Conrozier T, Mathieu P, Bonjean M, Marc JF, Renevier JL, Balblanc JC. A complex of three natural anti-inflammatory agents provides relief of osteoarthritis pain. Altern Ther Health Med. 2014;20:32-37.

23.
de Silva V, El-Metwally A, Ernst E, Lewith G, Macfarlane GJ. Evidence for the efficacy of complementary and alternative medicines in the management of osteoarthritis: a systematic review. Rheumatol. 2011;50:911-920. crossref(new window)

24.
Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis: the role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am. 1999;25:379-395. crossref(new window)

25.
Deodhar SD, Sethi R, Srimal RC. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res. 1980;71:632-634.

26.
Ezaki J, Hashimoto M, Hosokawa Y, Ishimi Y. Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal model. J Bone Miner Metab. 2013;31:16-25. crossref(new window)

27.
Fiebich BL, Heinrich M, Hiller KO, Kammerer N. Inhibition of TNF-alpha synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine. 2001;8:28-30. crossref(new window)

28.
Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S, Jan S, March L, Edmonds J, Norton R, Woodward M, Day R. LEGS study collaborative group. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015;74:851-858. crossref(new window)

29.
Fransen M, Bridgett L, March L, Hoy D, Penserga E, Brooks P. The epidemiology of osteoarthritis in Asia. Int J Rheum Dis. 2011;14:113-121. crossref(new window)

30.
Frondoza CG, Sohrabi A, Polotsky A, Phan PV, Hungerford DS, Lindmark L. An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cell Dev Biol Anim. 2004; 40:95-101.

31.
Gagnier JJ, VanTulder MW, Berman B, Bombardier C. Herbal medicine for low back pain: a Cochrane review. Spine. 2007;32:82-92. crossref(new window)

32.
Gregory PJ, Sperry M, Wilson AF. Dietary supplements for osteoarthritis. Am Fam Phys. 2008;77:177-184.

33.
Grzanna R, Lindmark L, Frondoza CG. Ginger – an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005;8:125-132. crossref(new window)

34.
Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, Blanco FJ, Benito P, Martín-Mola E, Paulino J, Marenco JL, Porto A, Laffon A, Araújo D, Figueroa M, Branco J. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007;56:555-567. crossref(new window)

35.
Houpt JB, McMillan R, Wein C, Paget-Dellio SD. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol. 1999;26:2423-2430.

36.
Huang G, Xu Z, Huang Y, Duan X, Gong W, Zhang Y, Fan J, He F. Curcumin protects against collagen-induced arthritis via suppression of BAFF production. J Clin Immunol. 2013; 33:550-557. crossref(new window)

37.
Huskisson E. Glucosamine and chondroitin for osteoarthritis. J Int Med Res. 2008;36:1161-1179. crossref(new window)

38.
Imtiyaz S, Rahman K, Sultana A, Tariq M, Chaudhary SS. Zingiber officinale Rosc.: A traditional herb with medicinal properties. TANG. 2013;3:e26.

39.
Jackson CG, Plaas AH, Sandy JD, Hua C, Kim-Rolands S, Barnhill JG, Harris CL, Clegg DO. The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination. Osteoarthritis Cartilage. 2010;18:297-302. crossref(new window)

40.
Jang MH , Lim S, Han SM, Park HJ, Shin I, Kim JW, Kim NJ, Lee JS, Kim KA, Kim CJ. Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharm Sci. 2003;93:367-371. crossref(new window)

41.
Jin CY, Lee JD, Park C, Choi YH, Kim GY. Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia. Acta Pharmacol Sin. 2007;28:1645-1651. crossref(new window)

42.
Joe B, Rao UJ, Lokesh BR. Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin. Mol Cell Biochem. 1997;169:125-134. crossref(new window)

43.
Kahan A, Uebelhart D, De Vathaire F, Delmas PD, Reginster JY. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis. Arthritis Rheum. 2009;60:524-533. crossref(new window)

44.
Kim CS, Kawada T, Kim BS, Han IS, Choe SY, Kurata T, Yu R. Capsaicin exhibits anti-inflammatory property by inhibiting IkB-α degradation in LPS-stimulated peritoneal macrophages. Cell Signal. 2003;15:299-306. crossref(new window)

45.
Kim JH, Gupta SC, Park B, Yadav VR, Aggarwal BB. Turme ric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Mol Nutr Food Res. 2012;56:454-465. crossref(new window)

46.
Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage. 2006;14:286-294. crossref(new window)

47.
Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 agonist) therapy for pain relief: farewell or revival? Clin J Pain. 2008;24:142-154. crossref(new window)

48.
Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull. 1992;40:387-391. crossref(new window)

49.
Kopsidas G, MacPhee DG. Mutagenesis by 9-aminoacridine in Salmonella typhimurium: inhibition by glucose and other PTS class A carbon sources. Mutat Res. 1994;306:111-117. crossref(new window)

50.
Kumar K, Thakur AK, Verma S, Yadav V, Chatterjee SS. Potential of some traditionally used edible plants for prevention and cure of diabesity associated comorbidities. TANG. 2015;5:e8.

51.
Kundu JK, Mossanda KS, Na HK, Surh YJ. Inhibitory effects of the extracts of Sutherlandia frutescens (L.) R.Br. and Harpagophytum procumbens DC. On phorbolester-induced COX-2 expression in mouse skin: AP-1 and CREB as potential upstream targets. Cancer Lett. 2005;218:21-31. crossref(new window)

52.
Lamari FN, Theocharis AD, Asimakopoulou AP, Malavaki CJ, Karamanos NK. Metabolism and biochemical/physiological roles of chondroitin sulfates: analysis of endogenous and supplemental chondroitin sulfates in blood circulation. Biomed Chromatogr. 2006;20:539-550. crossref(new window)

53.
Largo R, Alvarez-Soria MA, Díez-Ortego I, Calvo E, Sánchez-Pernaute O, Egido J, Herrero-Beaumont G. Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage. 2003;11:290-298. crossref(new window)

54.
Laslett LL, Jones G. Capsaicin for osteoarthritis pain. Prog Drug Res. 2014;68:277-291.

55.
Lippiello L, Woodward J, Karpman R, Hammad TA. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clin Orthop Relat Res. 2000;381:229-240. crossref(new window)

56.
Maccagno A, Di Giorgio EE, Caston OL, Sagasta CL. Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis. Am J Med. 1987;83:72-77. crossref(new window)

57.
Mazières B, Hucher M, Zaim M, Garnero P. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2007;66:639-645. crossref(new window)

58.
Mncwangi N, Chen W, Vermaak I, Viljoen AM, Gericke N. Devil’s claw – a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens. J. Ethnopharmacol. 2012;143:755-771. crossref(new window)

59.
Monfort J, Nacher M, Montell E, Vila J, Verges J, Benito P. (2005). Chondroitin sulfate and hyaluronic acid (500-730 kDa) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes. Drugs Exp Clin Res. 2005;31:71-76.

60.
Morelli V, Naquin C, Weaver V. Alternative therapies for traditional disease states: osteoarthritis. Am Fam Phys. 2003;67:339-344.

61.
Na HK, Mossanda KS, Lee JY, Surh YJ. Inhibition of phorbolester- induced COX-2 expression by some edible African plants. Biofactors. 2004;21:149-153. crossref(new window)

62.
Najm WI, Reinsch S, Hoehler F, Tobis JS, Harvey PW. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. BMC Musculoskelet Disord. 2004;5:6. crossref(new window)

63.
Notoya K, Jovanovic DV, Reboul P, Martel-Pelletier J, Mineau F, Pelletier JP. The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol. 2000;165:3402-3410. crossref(new window)

64.
O’Neill J, Brock C, Olesen AE, Andresen T, Nilsson M, Dickenson AH. Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev. 2012;64:939-971. crossref(new window)

65.
Okazaki J, Kamada A, Matsukawa F, Sakaki T, Gonda Y. Disaccharide analysis of chondroitin sulphate in human gingival crevicular fluid using high-performance liquid chromatography. Arch Oral Biol. 1995;40:777-779. crossref(new window)

66.
Owens S, Wagner P, Vangness CT. Recent advances in glucosamine and chondroitin supplementation. J Knee Surg. 2004;17:185-193.

67.
Park C, Moon DO, Choi IW, Choi BT, Nam TJ, Rhu CH, Kwon TK, Lee WH, Kim GY, Choi YH. Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med. 2007;20:365-372.

68.
Park JS, Choi MA, Kim BS, Han IS, Kurata T, Yu R. Capsaicin protects against ethanol-induced oxidative injury in the gastricmucosa of rats. Life Sci. 2000;67:3087-3093. crossref(new window)

69.
Park SY, Kim YH, Kim Y, Lee SJ. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells. J Cell Biochem. 2012;113:3653-3662. crossref(new window)

70.
Pavelka K, Gatterová J, Olejarová M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulphate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002;162:2113-2123. crossref(new window)

71.
Pouwels MJ, Jacobs JR, Span PN, Lutterman JA, Smits P, Tack CJ. Short-term glucosamine infusion does not affect insulin sensitivity in humans. J Clin Endocrinol Metab. 2001;86:2099-2103.

72.
Rainsford KD. Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs). Am J Med. 1999;107:27-35. crossref(new window)

73.
Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357:251-256. crossref(new window)

74.
Ronca G, Conte A. Metabolic fate of partially depolymerized shark chondroitin sulfate in man. Int J Clin Pharmacol Res. 1993;13:27-34.

75.
Rovati LC, Annefeld M, GiacovelliI G, Schmid K, Setnikar I. Glucosamine in osteoarthritis. Lancet. 1999;354:1640-1642. crossref(new window)

76.
Rovetta G, Monteforte P, Molfetta G, Balestra V. Chondroitin sulfate in erosive osteoarthritis of the hands. Int J Tissue React. 2002;24:29-32.

77.
Schulze-Tanzil G, Hansen C, Shakibaei M. Effect of a Harpagophytum procumbens DC extract on matric metalloproteinases in human chondrocytes in vitro. Arzneimittelforschung. 2004;54:213-220.

78.
Setnikar I, Rovati LC. Absorption, distribution, metabolism and excretion of glucosamine sulfate. Arzneimittel forschung. 2001;51:699-725.

79.
Stewart KM, Cole D. The commercial harvest of Devil’s Claw (Harpagophytum spp.) in southern Africa: the devil’s in the details. J Ethnopharmacol. 2005;100:225-236. crossref(new window)

80.
Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev. 1999;51:159-212.

81.
Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt JB, Welch V, Hochberg MC, Wells GA. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2009; CD002946.

82.
Uebelhart D, Malaise M, Marcolongo R, DeVathairell F, Piperno M, Maileux E, Fioravanti A, Matoso L, Vignon E. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage. 2004;12:269-276. crossref(new window)

83.
Usha PR, Naidu MU. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Investig. 2004;24:353-363. crossref(new window)

84.
van Wyk BE. A broad review of commercially important southern African medicinal plants. J Ethnopharmacol. 2008;119:342-355. crossref(new window)

85.
Vetter G. Topical therapy of arthroses with glucosamines (Dona 200). Munch Med Wochenschr. 1969;111:1499-1502.

86.
Wolfe MM, Lichtenstein DR, Singh G. 1999. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. New Engl J Med. 1999;340:1888-1899. crossref(new window)